Research Highlights 04-2000

Two separate studies have found promising results in combination Rituxan/CHOP chemotherapy for patients with non-Hodgkin lymphoma (NHL). Researchers from Roswell Park Memorial Institute reported three-year follow-up data in patients with low-grade or follicular NHL who received combination regimens.

• Combination Rituxan/CHOP Chemotherapy for NHL Provides Prolonged Response Rates
• Rituxan Shows improved Response in Chronic Lymphocytic Leukemia
• Rituxan Shows Activity Against Multiple Myeloma
• New Antibody Therapy Provides Remission in Some Patients With AML
• Rituxan Shown to increase Responses in Non-Hodgkin’s
• Lymphoma Adriamycin/Taxol Combination Shows Superiority Over FAC in Metastatic Breast Cancer
• Weekly Combination Paclitaxel/Herceptin Therapy Effective in Metastatic Breast Cancer
• Goserelin/Tamoxifen Reduces Recurrences in Premenopausal Patients With Breast Cancer
• Weekly High-Dose Neoadjuvant Paclitaxel Effective in Advanced-Stage Breast Cancer
• Anastfozoie Is as Effective as Tamoxifen for First-Line Therapy in Metastatic Breast Cancer